Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
2.070
-0.960 (-31.68%)
At close: Oct 14, 2026, 4:00 PM EDT
1.940
-0.130 (-6.28%)
After-hours: Oct 14, 2026, 7:59 PM EDT
Alaunos Therapeutics Market Cap
Alaunos Therapeutics has a market cap or net worth of $5.26 million as of October 14, 2026. It is the 43,042nd most valuable company in the world and the 5,792nd biggest in the United States. Its market cap has decreased by 26.96% in one year.
Market Cap
5.26M
Enterprise Value
5.13M
1-Year Change
-26.96%
Global Rank
Country Rank
#5,792 United States
Category
ChartMarket Cap Chart
Since September 22, 2006, Alaunos Therapeutics's market cap has decreased from $76.30M to $5.26M, a decrease of -93.11%. That is a compound annual growth rate of -12.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 5.26M | -26.96% |
| Dec 31, 2025 | 7.20M | 132.26% |
| Dec 31, 2024 | 3.10M | -81.76% |
| Dec 29, 2023 | 17.00M | -87.88% |
| Dec 30, 2022 | 140.30M | -40.45% |
| Dec 31, 2021 | 235.60M | -56.37% |
| Dec 31, 2020 | 540.00M | -36.81% |
| Dec 31, 2019 | 854.50M | 220.88% |
| Dec 31, 2018 | 266.30M | -54.69% |
| Dec 29, 2017 | 587.70M | -16.61% |
| Dec 30, 2016 | 704.80M | -35.20% |
| Dec 31, 2015 | 1.09B | 108.89% |
| Dec 31, 2014 | 520.70M | 43.36% |
| Dec 31, 2013 | 363.20M | 9.66% |
| Dec 31, 2012 | 331.20M | 9.71% |
| Dec 30, 2011 | 301.90M | 33.41% |
| Dec 31, 2010 | 226.30M | 198.94% |
| Dec 31, 2009 | 75.70M | 510.48% |
| Dec 31, 2008 | 12.40M | -83.49% |
| Dec 31, 2007 | 75.10M | -17.56% |
| Dec 29, 2006 | 91.10M | 19.40% |
| Sep 22, 2006 | 76.30M | - |
View and export this data all the way back to 2006. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Moleculin Biotech | 8.48M |
| Bolt Biotherapeutics | 8.25M |
| Senti Biosciences Holdings | 7.94M |
| CNS Pharmaceuticals | 7.82M |
| Niki BioSolutions | 7.71M |
| CalciMedica | 7.65M |
| Aprea Therapeutics | 7.55M |
| Exicure | 7.53M |